Luk Vandenberghe, PhD

The strategic licensing agreement between Lonza and Massachusetts Eye and Ear® underscores Lonza’s position as a leading AAV manufacturing service provider and offers customers unprecedented technology and services to commercialize next generation gene...

Faculty Awards Joseph Arboleda-Velasquez, MD, PhD, and co-PI, Leo Kim, MD, PhD, received a Department of Defense grant in the amount of $1,499,592 over three years, for their project, "Testing the Preclinical Efficacy of Therapies for Proliferative...

Selecta is licensing Anc80 from Massachusetts Eye and Ear for a rare genetic disease with options on additional pre-specified indications. By combining Anc80 with Selecta’s investigational drug candidate, SVP-Rapamycin (SEL-110), Selecta is seeking to...

Jason Comander, MD, PhD, received a Foundation Fighting Blindness Enhanced Career Development Award in the amount of $510,000 over three years. Meredith Gregory-Ksander, PhD, received a grant from ONL Therapeutics in the amount of $59,739 over one year to...

Claes H. Dohlman, MD, PhD, and Joan W. Miller, MD, were appointed honorary Heed Fellows. C. Stephen Foster, MD, Massachusetts Eye Research and Surgery Institution, was included in the "America's Best Physicians" registry for 2016 as a top doctor in...

Dong Feng Chen, PhD, received a National Institutes of Health/National Eye Institute R01 grant in the amount of $2,462,500 over five years for her project, "The molecular basis underlying optic nerve growth in development and regeneration." Miguel...

Boston, MA Researchers at Massachusetts Eye and Ear and Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina. This discovery, published July 30 in Cell...